In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side ...

Social media advertisements of weight-loss drugs such as Wegovy and Mounjaro is illegal as per the India law, lawyers tell ...

The average participant getting a 12-mg weekly injection lost 71 pounds in 68 weeks.  "This is beyond what we see with any ...

The pharmaceutical leader has established itself as the leader in the fast-growing weight loss market. And although many other drugmakers are hot on its tail, Lilly has consistently demonstrated that, ...

Healthy snacks are in demand as meals are being “swapped for grazing” as the rise of weight-loss jabs encourages a “change in ...

Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by ...

Popular new anti-obesity medications can help people lose 10% to 20% of their body weight, yet a new study indicates that ...

Eli Lilly ( LLY 2.00%) recently announced stellar results from a phase 3 clinical trial, Triumph-4, which evaluated efficacy ...

I am a 68-year-old female who was first diagnosed with osteopenia and now osteoporosis. My physician has highly recommended ...

Obesity is a big driver of healthcare spending in South Africa, yet most medical schemes still limit cover for effective treatments. The gap between the scale of the problem and the funding response ...

Vikrant Shrotriya, Novo Nordisk India MD responds to questions on future pricing, generics competition post patent expiry in March, Indian-specific pricing, demand in India & quality. “India is not a ...

The class of GLP-1 agonist medications act by lowering the appetite with applications way beyond diabetes. These medicines ...